Policy & Compounding
Lifestyle Habits Stacked Against Peptides: Which Makes You Live Longer
Most peptides in a wellness stack have zero human trials. See what the research shows, and the 12-year gap five basic habits produced.
Science & Research
The trials, pipelines and studies behind the headlines.
Policy & Compounding
1 in 18 Black Market Peptide Vials Matched Its Label
An Australian lab tested 18 vials sold as retatrutide. One matched its label. See what the dosing errors were and why a purity test proves little.
Science & Research
Walking Gets You Most of the Longevity Benefit, and Tops Out Sooner Than You Think
The longevity benefit of walking plateaus at 6,000 to 8,000 steps after 60. See what the research says and why strength gets mentioned on a GLP-1.
Science & Research
Blocking GLP-1 for 16 Weeks Caused No Weight Regain for Those with Post-Bariatric Hypoglycemia
Avexitide blocks the GLP-1 receptor and cut severe blood sugar crashes 55%, with no weight change in either group. What that means if you take a GLP-1
Policy & Compounding
People Are Injecting 'Barbie Peptides' to Tan. Here's What the FDA Actually Says About Melanotan
Melanotan II is sold as a tanning shortcut. See the FDA's own safety language, the published case reports, and where the 2026 peptide review stands.
Science & Research
The FDA Wants to Limit Where Compounded GLP-1s Come From
The FDA proposed limiting large-scale compounded GLP-1s. See what is actually being decided and which pathway stays open.
More in Science & Research
- Policy & Compounding
FDA Panel Backs 6 Peptides for Compounding: What's Next
An FDA panel backed 6 of 7 peptides for the compounding list. See the votes, what each was proposed to treat, and what has to happen next.
- Lifestyle & Nutrition
PCOS Is Now PMOS: What the Name Change Means for You
PCOS has been renamed PMOS. See what the new name means, why it changed, and what the research shows about GLP-1s for this common condition.
- Science & Research
GLP-1s and Lower Breast Cancer Risk: What a Study Found
A Penn Medicine study of 110,000+ women links GLP-1 use to about 30% lower breast cancer risk. See what it found, its limits, and what it means.
- Policy & Compounding
The FDA Peptide Panel: Could These 7 Be Compounded?
An FDA panel meets July 23-24 to weigh whether 7 peptides can be compounded. See which peptides, what the FDA recommends, and what it means.
- Science & Research
MariTide: The Once-Monthly Weight-Loss Shot in Testing
MariTide is an experimental once-monthly weight-loss shot in Phase 3. See how it works, what trials showed, and how it compares to weekly shots.
- Cost & Coverage
The GLP-1 Price War: What Cheaper Options Mean for You
Brand GLP-1 cash prices are falling fast. See what Ozempic, Wegovy, and Zepbound cost now, why, and whether your own bill will drop.
